Prescription drug · ANDA
Methenamine Hippurate NDC 50268-549
Methenamine hippurate 1000 mg/1 · Tablet · Oral · AvPAK
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50268-549-15 | 5026805491550268054915 | 50 BLISTER PACK in 1 CARTON (50268-549-15) / 1 TABLET in 1 BLISTER PACK (50268-549-11)Marketed from Dec 2, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methenamine Hippurate
- Generic name (nonproprietary)
- methenamine hippurate
- Active ingredients
- Methenamine hippurate — 1000 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- AvPAKNDC labeler code 50268
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212172
- Marketing start
- Listing expires
- Identifiers
- Product ID 50268-549_0e88fdee-dba1-56cd-e063-6394a90a47c6SPL ID 0e88fdee-dba1-56cd-e063-6394a90a47c6SPL set ID b581b655-62a4-2aa9-e053-2a95a90aa823RxCUI 992150UNII M329791L57
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450268054915followed by a unit qualifier and the quantityPackage 50268-0549-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Methenamine hippurate tablets USP are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents. To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate and other antibacterial drugs, methenamine hippurate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or mod…
Excerpt only. Read the full label for complete information.
About NDC 50268-549
- What is NDC 50268-549?
- 50268-549 is the product NDC for Methenamine Hippurate, Methenamine hippurate 1000 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methenamine Hippurate.
- What is the active ingredient?
- Methenamine hippurate.
- Who is the labeler?
- AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methenamine Hippurate?
- 11 other product NDCs are listed under this name. See all Methenamine Hippurate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methenamine Hippurate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | ANI Pharmaceuticals, Inc. | 70954-959 | 70954-0959-10 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | NorthStar Rx LLC | 72603-816 | 72603-0816-01 |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Zydus Lifesciences Limited | 70771-1919 | 70771-1919-01 |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-175 | 72578-0175-01 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-797 | 59746-0797-0159746-0797-65 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | American Health Packaging | 60687-694 | 60687-0694-21 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-142 | 50742-0142-01 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-880 | 51407-0880-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | Micro Labs Limited | 42571-332 | 42571-0332-0142571-0332-23 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Aurobindo Pharma Limited | 65862-782 | 65862-0782-01 |
Other NDCs under ANDA 212172
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | Micro Labs Limited | 42571-332 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | American Health Packaging | 60687-694 |